Osteoporosis is a major public health problem worldwide, especially among the postmenopausal women due to a dramatic reduction of estrogen level1.Currently, the only clinically available anabolic agent for osteoporosis is parathyroid hormone (PTH)2.Tryptophan hydroxylase 1 (Tph-1) is the principal enzyme in the biosynthesis of peripheral serotonin.